These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Toxicity of infliximab in the course of treatment of Crohn's disease. Bratcher JM; Korelitz BI Expert Opin Drug Saf; 2006 Jan; 5(1):9-16. PubMed ID: 16370952 [TBL] [Abstract][Full Text] [Related]
4. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review. Atzeni F; Sarzi-Puttini P; Doria A; Iaccarino L; Capsoni F Autoimmun Rev; 2005 Mar; 4(3):144-52. PubMed ID: 15823500 [TBL] [Abstract][Full Text] [Related]
5. [Suspected cases of severe side effects after infliximab (Remicade) in Germany]. Andus T; Stange EF; Höffler D; Keller-Stanislawski B Med Klin (Munich); 2003 Aug; 98(8):429-36. PubMed ID: 12928808 [TBL] [Abstract][Full Text] [Related]
6. [Indications and results of infliximab in Crohn's disease]. Karoui S; Boubaker J; Filali A Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505 [TBL] [Abstract][Full Text] [Related]
7. Infliximab use in luminal Crohn's disease. Richter JA; Bickston SJ Gastroenterol Clin North Am; 2006 Dec; 35(4):775-93. PubMed ID: 17129813 [TBL] [Abstract][Full Text] [Related]
8. A review of infliximab use in ulcerative colitis. Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261 [TBL] [Abstract][Full Text] [Related]
9. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Katz JA; Antoni C; Keenan GF; Smith DE; Jacobs SJ; Lichtenstein GR Am J Gastroenterol; 2004 Dec; 99(12):2385-92. PubMed ID: 15571587 [TBL] [Abstract][Full Text] [Related]
10. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity. Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874 [TBL] [Abstract][Full Text] [Related]
11. Guidelines for treatment with infliximab for Crohn's disease. Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G; Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083 [TBL] [Abstract][Full Text] [Related]
12. Review article: Infliximab therapy for inflammatory bowel disease--seven years on. Rutgeerts P; Van Assche G; Vermeire S Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465 [TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q; Hogezand RA; Lamers CB; Verspaget HW Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330 [TBL] [Abstract][Full Text] [Related]
14. [Infliximab therapy for Crohn's disease - a practical guideline: actualised consensus of the working group for chronic inflammatory bowel diseases of the Austrian Society for Gastroenterology and Hepatology]. Reinisch W; Dejaco C; Feichtenschlager T; Haas T; Kaser A; Miehsler W; Novacek G; Petritsch W; Platzer R; Tilg H; Vogelsang H; Knoflach P; Z Gastroenterol; 2011 Apr; 49(4):534-42. PubMed ID: 21442574 [TBL] [Abstract][Full Text] [Related]
15. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis. Chan CY; Browning JC; Larsen F; Hsu S Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594 [TBL] [Abstract][Full Text] [Related]
16. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks. Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832 [TBL] [Abstract][Full Text] [Related]
17. Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study. Atzeni F; Ardizzone S; Sarzi-Puttini P; Colombo E; Maconi G; De Portu S; Carrabba M; Bianchi Porro G Aliment Pharmacol Ther; 2005 Sep; 22(5):453-61. PubMed ID: 16128684 [TBL] [Abstract][Full Text] [Related]
18. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204 [TBL] [Abstract][Full Text] [Related]
19. [Improvement of bone metabolism after infliximab therapy in Crohn's disease]. Miheller P; Muzes G; Zágoni T; Tóth M; Rácz K; Tulassay Z Orv Hetil; 2005 Jul; 146(28):1477-80. PubMed ID: 16130441 [TBL] [Abstract][Full Text] [Related]